CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Betalin aims to enhance the longevity and performance of transplanted insulin-producing beta cells for Type 1 Diabetes patients by using acellular micro-scaffolds derived from tissue. This technology seeks to create a supportive environment for beta cells, improving their stability and function post-transplant.
Betalin’s mission is to provide a tissue-derived acellular micro-scaffold that will extend the life and the insulin-producingperformance of transplanted beta cells in order to reduce or eliminate the dependence of some diabetics on insulin therapy.Type 1 Diabetes is a chronic disease that results from the autoimmune destruction of the insulin-producing beta cells in thepancreas.
Its cause is still uncertain and there is no known way to prevent its onset.
With~70,000 new cases diagnosedeach year,…
BETALIN THERAPEUTICS LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
